Skip to main content
Premium Trial:

Request an Annual Quote

Tataa Biocenter to Distribute Lexogen's NGS Products in Europe

NEW YORK (GenomeWeb) – Tataa Biocenter and Lexogen announced today that they have formed a strategic collaboration under which Tataa will distribute Lexogen's next-generation sequencing products in certain European markets. 

Specifically, Tataa will distribute Lexogen's library construction kits in Sweden, Denmark, Norway, Germany, Austria, France, Luxemburg, Slovakia, and the Czech Republic. Under the terms of the deal, Tataa will also incorporate Lexogen's products into the NGS training courses it holds in various European locations. 

Additional terms of the agreement were not disclosed.

"Our customers request professional tools for the entire NGS workflow from sample preparation and quality control to library preparation, sequencing, and data analysis," Tataa President Mikael Kubista said in a statement. "With Lexogen's library construction kits, we can help our customers performing transcription analysis with RNA sequencing at much greater accuracy, reduced cost, and higher quality."

The deal with Lexogen is the latest in a string of European distribution arrangements Tataa has formed recently. Last month, the company inked a deal to distribute Swift Biosciences' NGS products and include them in its training courses.

It signed a similar agreements with Yikon for its MALBAC single-cell whole-genome amplification products in February and with Strand Life Sciences for its NGS data analysis software last June. 

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.